Independent peptide research

The science behind peptides, clearly explained

PeptideMark is the most comprehensive evidence-based peptide reference on the internet. Every claim cited. Every compound evidence-rated. No hype, no vendor influence — just research.

20+ compounds profiled100% claims cited4-tier evidence rating$0 vendor influence

Featured compounds

Healing & Recovery

BPC-157Body Protection Compound-157, Bepecin

A gastric pentadecapeptide studied extensively in animal models for tissue healing, gut protection, and cytoprotective properties. Despite over 100 preclinical studies, human clinical data remains extremely limited.

Preliminary EvidenceBanned from Compounding (Category 2)WADA banned9 studies cited
Weight Loss

SemaglutideOzempic, Wegovy

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management.

Strong EvidenceFDA Approved6 studies cited
Weight Loss

TirzepatideMounjaro, Zepbound

An FDA-approved dual GIP/GLP-1 receptor agonist that has shown the highest weight loss results of any approved medication.

Strong EvidenceFDA Approved5 studies cited
Healing & Recovery

TB-500Thymosin Beta-4, TB4

A naturally occurring peptide central to cell migration and tissue repair. Phase 2 human wound healing trials showed accelerated healing; also studied for cardiac and corneal repair.

Moderate EvidenceBanned from Compounding (Category 2)WADA banned5 studies cited
Weight Loss

RetatrutideLY3437943, Triple Agonist

A triple-acting GIP/GLP-1/glucagon receptor agonist in Phase 3 trials showing potentially the highest weight loss of any drug in development.

Moderate EvidenceIn Clinical Trials1 studies cited
Immune Support

Thymosin Alpha-1Tα1, Thymalfasin

A naturally occurring thymic peptide approved internationally for immune modulation, with extensive clinical data in hepatitis and cancer immunotherapy.

Strong EvidenceResearch Only1 studies cited

The Peptide Brief

Weekly research digest. New studies, regulatory updates, and expert analysis — no spam, no vendor pitches.

Free. Unsubscribe anytime.

Why PeptideMark

Every claim is cited

PubMed IDs, named studies, FDA documents. If we can't cite it, we don't print it.

Evidence is rated honestly

Our 4-tier system distinguishes human RCTs from animal studies. No conflation, no cherry-picking.

Updated continuously

Weekly PubMed and FDA monitoring. Every compound page shows its last review date.